GREAT POINT PARTNERS LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q2 2020$5,531,000
-88.5%
58,056
-89.2%
0.44%
-91.2%
Q1 2020$48,137,000
-9.2%
535,627
-46.4%
5.03%
+8.9%
Q4 2019$53,020,000
-7.8%
1,000,000
-31.3%
4.62%
-12.6%
Q3 2019$57,475,000
-99.9%
1,454,700
+0.4%
5.28%
-20.1%
Q2 2019$59,537,000,000
+118261.5%
1,449,300
+34.2%
6.61%
+32.7%
Q1 2019$50,301,000
+11.4%
1,080,113
+4.2%
4.98%
-12.7%
Q4 2018$45,143,000
-14.1%
1,036,575
+12.9%
5.71%
-30.3%
Q3 2018$52,524,000
-23.7%
917,767
-35.3%
8.19%
-14.2%
Q2 2018$68,811,000
-99.6%
1,418,200
+206.8%
9.54%
+255.3%
Q1 2018$18,074,000,000
+245905.2%
462,245
+167.0%
2.68%
+114.0%
Q4 2017$7,347,000
+15.8%
173,124
+1.8%
1.25%
+1.6%
Q3 2017$6,344,000
-57.7%
170,000
-65.6%
1.23%
-54.1%
Q2 2017$14,997,000
+88.9%
493,500
+64.5%
2.69%
+70.4%
Q1 2017$7,941,000300,0001.58%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders